The Changing Nature of Evidence
In this recorded plenary session at the 2021 Annual Research Meeting, panelists discuss the ways in which, through evidence, data, experience and artificial intelligence, the very nature of evidence is changing.
Carolyn i s the CEO of Aetion, the digital health company delivering the platform that turns real-world data into the regulatory-grade evidence needed to inform health care’s most critical decisions: which treatments work best, for whom, when, and how much we should pay for them.
Before Aetion, Carolyn held leadership roles at three companies central to the shift from volume to value i n health care. As CEO of Remedy Partners, she l ed the premier company for bundled payments software and services. As Executive Vice President of Payer Strategy and Operations at Evolent Health, she l ed the team responsible for establishing value-based contracts on behalf of health systems and provider-led health plans.
During her four year tenure, Evolent progressed from start-up through IPO to become a major force i n health systems embracing population health. For the preceding eight years, Carolyn served i n leadership positions i n the Medicare and Medicaid businesses of UnitedHealth Group. Her roles included Chief Operating Officer of i ts Community and State plan i n New Jersey, and the national Vice President of Medicare Special Needs Plans, supporting people with multiple chronic illnesses and limited incomes.
Carolyn has an undergraduate degree from Harvard University and an MBA i n health care management from the Wharton School of Business at the University of Pennsylvania. She serves on the board of the Center for Health Policy Development, and of Parity.org, an organization that She also serves on the Entrepreneurial Council of United States of Care, a bipartisan nonprofit focused on improving access to quality health care.